Literature DB >> 26019437

Issues with normative data of hippocampal volumetry in Indian population.

Kuljeet Singh Anand1, Vikas Dhikav1, Sharmila Doraswamy2, Umesh Chandra Garga2.   

Abstract

Entities:  

Year:  2015        PMID: 26019437      PMCID: PMC4445215          DOI: 10.4103/0972-2327.150607

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


× No keyword cloud information.
Sir, We read the paper entitled, “Hippocampal volumetry: Normative data in Indian population[1]” with great interest. The paper has attempted to give the normative data of hippocampal volumes in Indian population. The paper, though written well, could have been better if it clarified some of the issues: Paper mixes two issues of medial temporal sclerosis with hippocampal atrophy of Alzheimer's disease and other dementias. Both however are different issues. Only a very small number of Alzheimer's disease patients have hippocampal sclerosis. How could the paper extrapolate the data from the adults to elderly? Present study has taken adults, and given the normative data using 200 adults. The sample size calculations for the same have not been mentioned. How did the authors arrive at the figure of 200? Sampling method could have been mentioned. Implications of volumetry in medial temporal sclerosis (MTS) could have been mentioned apart from lateralization. Authors could have discussed more about the difference in the findings of hippocampal volumes e.g. Western data, Asian and their own data. Why is this difference? What do they hypothesize? Means of hippocampal volumes have been given, but the paper does not mention standard deviation of the same. Means without standard deviation would not make much sense? How could one deduce limits of “ abnormal hippocampal volume/s” when standard deviations have not been given. Why was paired t-test used to know intra-rater variability and which 20 patients were chosen for the same? And why only 20? What decided the sample size calculations for the same? Intra-rater reliability coefficient could have been mentioned. Authors could specify which protocol of the review paper they have used and how was the calculation of area and volume was done as described by Konard et al.[2] Authors somehow attempt to extrapolate the data they obtained in young adults to older adults. This does not seem appropriate as hippocampus is a plastic and vulnerable structure[3] affected by several stimuli and moreover, medial temporal lobe gets affected by a variety of factors in patients with Dementias.[4]
  4 in total

1.  Medial temporal lobe atrophy in Alzheimer's disease/mild cognitive impairment with depression.

Authors:  V Dhikav; M Sethi; K S Anand
Journal:  Br J Radiol       Date:  2014-07-25       Impact factor: 3.039

Review 2.  Defining the human hippocampus in cerebral magnetic resonance images--an overview of current segmentation protocols.

Authors:  C Konrad; T Ukas; C Nebel; V Arolt; A W Toga; K L Narr
Journal:  Neuroimage       Date:  2009-05-15       Impact factor: 6.556

3.  Hippocampus in health and disease: An overview.

Authors:  Kuljeet Singh Anand; Vikas Dhikav
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

4.  Hippocampal volumetry: Normative data in the Indian population.

Authors:  Aravind Narayan Mohandas; Rose Dawn Bharath; Parthipulli Vasuki Prathyusha; Arun K Gupta
Journal:  Ann Indian Acad Neurol       Date:  2014-07       Impact factor: 1.383

  4 in total
  2 in total

1.  Correlation between hippocampal volumes and medial temporal lobe atrophy in patients with Alzheimer's disease.

Authors:  Vikas Dhikav; Sharmila Duraiswamy; Kuljeet Singh Anand
Journal:  Ann Indian Acad Neurol       Date:  2017 Jan-Mar       Impact factor: 1.383

2.  Hippocampal volumes among older Indian adults: Comparison with Alzheimer's disease and mild cognitive impairment.

Authors:  Vikas Dhikav; Sharmila Duraisamy; Kuljeet Singh Anand; Umesh Chandra Garga
Journal:  Ann Indian Acad Neurol       Date:  2016 Apr-Jun       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.